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Abstract 
Background: Autism Spectrum Disorder (ASD) is highly 
heterogeneous in etiology and manifestation. The 
neurobiological processes underlying ASD development are 
reflected in multiple features, from behavior and cognition to 
brain functioning. An integrated analysis of these features 
may optimize the identification of these processes.  
Methods: We examined cognitive and adaptive functioning, and 
ASD symptoms between 8 and 36 months in 161 infants at 
familial high-risk for ASD (HR) and 71 low-risk controls (LR), 
and neural sensitivity to eye-gaze at 8 months in a subsample 
of 140 HR and 61 LR. We used linked independent component 
analysis to extract patterns of variation across domains and 
development, and selected the patterns significantly 
associated with clinical classification at 36 months. 
Results: An early process at 8 months, indicating high levels 
of functioning and low levels of symptoms linked to higher 
attention to gaze shifts, was reduced in infants who developed 
ASD. A longitudinal process of increasing functioning and low 
levels of symptoms was reduced in infants who developed ASD, 
while another process suggesting a stagnation in cognitive 
functioning at 24 months was increased in infants who 
developed ASD. 
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Limitations: Although results show a clear significant trend 
relating to clinical classification, there was substantial 
overlap between groups. 
Conclusions: We uncovered underlying processes acting together 
early in development and associated with clinical outcome. 
Results highlight the complexity of emerging ASD, which goes 
beyond the borders of clinical categories. Future work should 
integrate genetic data to investigate the specific genetic 
risks linked to these processes. 
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Introduction 
Autism Spectrum Disorders (ASD) are behaviourally defined by 
difficulties in social-communication, restricted and 
repetitive patterns of behaviours and interests, and sensory 
anomalies1. The intrinsic heterogeneity of ASD is evident at 
different levels of analysis and points to multiple underlying 
biological mechanisms leading to the disorder2,3. Integration 
of information from multiple concurrent and longitudinal data 
might be crucial to decompose this variability4 and understand 
the complexity of ASD development. Data integration allows for 
a better understanding of the underlying biological mechanisms 
leading to different subgroups in phenotype by investigating 
their effects across multiple domains of functioning. This 
study aimed to uncover underlying processes early in 
development linked to later emergence of ASD. To do that, we 
looked for coherent patterns of variation across multiple 
developmental domains over time through an integrated 
analysis, in contrast to previous studies that have reported 
on categorical analyses that were only post-hoc associated 
across domains. 
Prospective longitudinal studies of infants at familial high-
risk for ASD (HR), based on having an older sibling with ASD, 
can inform on early manifestations of the disorder by 
investigating differences between infants who develop ASD and 
those who don’t5. There is a general consensus in the field 
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that the defining behavioural features of ASD are not present 
in the first year of life but begin to emerge around 12 months 
and consolidate between 18 and 36 months6,7. However, this pre-
symptomatic period is characterised by sensorimotor8-10 and 
visual attention11-14 atypicalities, and by alterations in brain 
structure15-17 and function18-20 in infants with later ASD 
outcome. In particular, infants developing ASD demonstrate 
emerging atypicalities in social-communicative behaviour from 
the first year of life, with a declining interest in human 
faces21-23 by 6 months of age. Event-related potentials (ERPs) 
provide a useful tool to examine the neural correlates of face 
recognition in infancy24 through the characteristic P1, N290, 
and P400 components, known to be modulated by direction of 
eye-gaze as early as 4 months of age25.  
Although valuable to identify potential early risk markers for 
ASD, the traditional case-control comparison approach 
overlooks the heterogeneity of clinical outcome groups, which 
often overlap across symptoms26. In fact, the idea of ASD as a 
discrete, separate entity can distort the investigation of the 
underlying mechanisms and early development of ASD. 
Unsupervised data-driven methods are particularly advantageous 
when there is no a-priori knowledge on the actual sample 
subgroups27 due to the absence of hypotheses for the inference 
of structure in unlabelled data. Here, we introduced a novel 
approach for prospective analysis of early development as 
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opposed to the more traditional retrospective investigation of 
early differences between categorical groups defined by ASD 
outcome. We separated underlying neurodevelopmental processes 
associated with clinical outcome based on the extraction of 
intrinsic patterns in multivariate unlabelled data through 
unsupervised learning methods. Our approach allows identifying 
different emerging patterns of development and investigating 
how they lead to specific outcomes by only looking at 
structure in the data. The identified patterns might then be 
the key to improve our understanding of individual 
heterogeneity and allow stratification into more homogeneous 
and predictable subgroups that might be a better target for 
early intervention. Compared to previous work on the same 
dataset10, this study shows a novel approach to prospective 
data. Our previous study used a more traditional analytic 
approach to examine differences in developmental trajectories 
between groups defined by current clinical categories, 
implicitly reinforcing existing clinical models. Here, we 
discover structure in data independently from clinical 
categories. Such approach potentially allows us to transform 
our understanding of the mechanisms underlying emerging ASD. 
Linked independent component analysis (ICA) can be used to 
simultaneously model and discover common features across 
multiple modalities28-30. Although mainly used in neuroimaging31-
33, this method can be directly applied to any type of 
8 
 
multimodal data acquired for a fixed group of participants. 
Applied to longitudinal multimodal data collected from large 
cohorts of infant siblings, it can help identify underlying 
biological processes with expression in different domains 
across development. In this study, we used linked ICA to 
uncover neurodevelopmental processes acting early in 
development by simultaneous factorization of developmental 
measures and electrophysiological measures of neural 
sensitivity to social and non-social stimuli at 8 months. The 
same approach was used to uncover underlying processes acting 
across development by simultaneous factorization of 
longitudinal developmental measures between 8 and 36 months. 
Then, we tested the post-hoc association of the identified 
processes to clinical outcome at 36 months. This provided 
novel insights into the neurodevelopmental processes acting 
together from early age and leading to different clinical 
outcomes depending on their presence at an individual level.  
Methods and Materials 
[Figure 1: Analysis flowchart] 
We performed two separate analyses (Figure 1): a multimodal 
analysis to identify early neurodevelopmental processes, and a 
longitudinal analysis to identify processes acting across 
development. 
Participants 
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Data were collected from infants recruited in one of two 
phases of the British Autism Study of Infant Siblings (BASIS, 
http://www.basisnetwork.org)18,34, involving infants considered 
at high risk for ASD based on having an older biological 
sibling with ASD (HR siblings), and low-risk controls (LR). 
All procedures were in agreement with ethical approval granted 
by the London Central NREC (approval codes 06/MRE02/73, 
08/H0718/76), and one or both parents gave informed consent to 
participate in the study. Experimenters were aware of infants’ 
risk status, but assessments were blind to clinical outcome. 
At the time of enrolment, none of the infants had been 
diagnosed with any developmental condition. 
The longitudinal sample included 232 infants (71 LR and 161 
HR) followed on four visits at 8.1±1.2 months (mean ± standard 
deviation; hereafter 8 months), 14.5±1.3 months (hereafter 14 
months), 25.4±3.1 months (hereafter 24 months) and 38.4±2.3 
(hereafter 36 months). To handle missing data, we performed 
imputation through expectation maximization on SPSS 
(http://www.ibm.com/analytics/us/en/technology/spss, see 
Supplemental Material for details). The multimodal analysis 
was run in a subsample of 201 infants (61 LR and 140 HR) 
selected because of having neural data available at 8 months 
(8.14±1.22 months). Both samples were balanced in sex (see 
Table 1). 
Measures 
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Developmental skills. Cognitive development was measured at 
each visit by the Mullen Scales of Early Learning (MSEL35), a 
standardized developmental measure assessing cognitive 
functioning in 5 scales: gross motor (GM), visual reception 
(VR), fine motor (FM), receptive (RL) and expressive language 
skills (EL). T-scores (mean=50; standard deviation, SD=10) 
from the 5 scales at 8 months were included as input features 
in the multimodal analysis. Gross motor scores were excluded 
from the longitudinal analysis as not available at 36 months, 
leading to 4 input features from the MSEL. 
Adaptive functioning. Adaptive behaviour was measured by the 
Vineland Adaptive Behavior Scales (VABS-II36), a semi-
structured parent-report questionnaire (at 8 and 14 months) or 
parent interview (at 24 and 36 months) assessing personal and 
social functioning in 4 different domains: Communication 
(Comm), Daily Living Skills (DL), Socialization (Soc) and 
Motor Abilities (Mot). Standard scores (mean=100; SD=15) from 
the 4 domains were included as input features in all analyses. 
Early ASD symptoms. A 19-item version of the Autism 
Observation Scale for Infants (AOSI), a semi-structured 
observational assessment37, was administered at 8 and 14 months 
to detect putative behavioural signs of ASD. The AOSI total 
score at 8 months was used as input feature in the multimodal 
analysis. To assess ASD symptomatology, the Autism Diagnostic 
Interview Revised (ADI-R38) was administered at 36 months and 
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the Autism Diagnostic Observation Schedule (ADOS-239) was 
administered at 24 and 36 months. Total scores from the AOSI 
at 8 and 14 months and from the ADOS at 24 and 36 months were 
included in the longitudinal analysis. 
Event-Related Potentials (ERPs). The task was the same as in 
Elsabbagh et al18. It was designed to assess responses to: 
static face [Fc]; visual noise stimuli [Ns]; static faces with 
direct gaze [FD]; static faces with averted gaze [FA]; gaze 
shifts toward the infant [SD]; gaze shifts away from the 
infant [SA]. Components P100, N290, and P400 averaged across 
occipito-temporal channels were quantified by amplitude and 
latency for a total of 36 ERP variables measured at 8 months 
and used as input features for the multimodal analysis (see 
Supplemental Material for details). 
Clinical outcome evaluation at 36 months 
The LR group was based on having an older full sibling with 
typical development. None of the LR infants met research 
criteria for ASD and none of them had a community clinical ASD 
diagnosis at 36 months (see Supplemental Material for 
details). Expert clinical researchers reviewed all available 
information on HR siblings at 24 months and 36 months and 
assigned clinical consensus best estimate diagnosis of ASD 
according to ICD-1040 in Phase 1, and DSM-5 criteria1 in Phase 
2. The best estimate diagnoses for the two phases were 
reviewed for differences in categorization and considered 
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similar. HR siblings were subsequently grouped into siblings 
with ASD (HR-ASD); with atypical (non-ASD) development (HR-
Atypical); and with typical development (HR-Typical) (see 
Supplemental Material for details).  
Statistical Analysis 
Linked ICA is a Bayesian extension of independent component 
analysis (ICA) for unsupervised learning of statistically 
independent modes of variation in data29,41, allowing for the 
simultaneous analysis of multimodal data collected on the same 
participants28. The identified components indicate processes 
considered independent based on how they affect different 
measures (i.e. across behavioural or neural data), but linked 
across modalities (i.e. behavioural versus brain data, Figure 
1A) or time-points (Figure 1B). Each component explains 
variation within the individual participant and is represented 
by: (1) a vector of individual loadings, namely scalar values 
indicating how much that component explains developmental 
variation for the individual participant; (2) component 
weightings in different modalities; (3) a score map, 
indicating the relative value of scores compared to the 
estimated noise in individual variation. For the 
implementation, we used the code available on the FSL homepage 
(http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FLICA). The number of 
independent components was estimated such that more than 90% 
of variance was explained. 
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In the multimodal analysis, we integrated measures of 
developmental level (10 total features from MSEL, VABS and 
AOSI) and ERP data at 8 months (36 total features; Figure 
1A.1). The number of components was estimated to be 10. In the 
longitudinal analysis, we integrated developmental data (9 
total features from MSEL, VABS and AOSI/ADOS) between 8 and 36 
months. Different time-points were considered as different 
input modalities (Figure 1B.1) but were not considered as 
ordinal. The number of components was estimated to be 9. 
We evaluated the association of the extracted components with 
clinical outcome through regression, with clinical outcome at 
36 months as independent variable, individual component 
loadings as dependent variable, and sex as covariate (Figure 
1A.3, 1B.3). We used Holm-Bonferroni correction to correct for 
multiple comparisons (Figure 1A.4, 1B.4). Differences in 
competence at different time-points, computed as average of 
MSEL and VABS scores, were tested via t-tests in robust 
ranges, and considered significant for p<0.05/6=0.008 
(tests=6). 
Results 
Data  
Demographics are shown in Table 1, while clinical 
characteristics of the two samples can be found in the 
Supplemental Material (Table S3 and Table S4). Clinical 
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outcome groups did not differ in age at any visit, while sex 
was significantly different per clinical outcome (2(3)=11.55, 
p=0.009 in the multimodal analysis; 2(3)=9.66, p=0.022 in the 
longitudinal analysis), with more males among the HR-ASD 
group.  
[Table 1. Demographics] 
Multimodal patterns of developmental and ERP data 
[Figure 2. Independent component linked across modalities] 
Among the 10 components across behavioural and brain data at 8 
months, one was significantly associated to clinical outcome 
at 36 months (IC7: =-0.29, p<0.001; Figure 2). This was a 
multimodal component (Figure 2C) showing a pattern in ERP 
variables (Figure 2A) characterized by longer P1 latency in 
response to gaze shifting away; higher P400 amplitude, lower 
P1 amplitudes and shorter N290 latency in responses to gaze 
shifts towards and away from the infant; and lower P1 
amplitude in response to visual noise. The linked pattern in 
clinical measures at 8 months showed high levels of competence 
across all functional domains and low level of early ASD 
symptoms (Figure 2B). In particular, scores were higher in 
gross motor, visual reception, and receptive language MSEL 
scores, and communication and motor VABS scores. Individual 
loadings were negatively associated to clinical outcome (=-
0.29, Figure 2D), meaning that the identified process was 
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present more strongly in typical development. The effect of 
sex covariate was not significant after Holm-Bonferroni 
correction (=-0.37 towards males, p=0.007).  
Longitudinal patterns of developmental data 
[Figure 3. Independent components linked across development] 
Using longitudinal developmental measures, two components were 
significantly associated to clinical outcome at 36 months 
(IC1: =-0.60, p<0.001; and IC3: =0.22, p<0.001). IC1 (Figure 
3, top row) was characterized by increasing competence across 
domains of cognitive and adaptive functioning between 8 and 36 
months, reaching the peak in communication, daily living and 
social skills at 36 months, while the level of ASD symptoms 
was low over time (Figure 3A). Development of competence 
increased significantly between 8 and 14 months (t(7)=-3.99, 
p=0.005), and between 14 and 24 months (t(7)=-8.25, p<0.001), 
while the increase between 24 and 36 months was not 
significant (t(7)=-2.73, p=0.029) (Figure 3D). The identified 
process mostly explained variance from measures at 24 and 36 
months (Figure 3B) and was negatively associated to clinical 
outcome (=-0.60, Figure 3C), meaning that it was present more 
strongly in typical development. In fact, individual loadings 
on this component were higher in LR controls and HR-Typical 
than HR-Atypical and HR-ASD siblings (Figure 3C). The effect 
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of sex covariate was not significant (=-0.04 towards males, 
p=0.73). 
IC3 (Figure 3, bottom row) explained mostly variance on measures 
at 24 and 36 months (Figure 3F). It started with low levels of 
cognitive abilities at 8 months, followed by an increase in ASD 
symptom severity, visual receptive abilities and motor abilities 
(MSEL fine motor and VABS motor scores) by 24 months, and by a 
further increase in severity of ASD symptoms and a plateau in 
cognitive and adaptive functioning at 36 months (Figure 3E). In 
particular, average competence across cognitive and adaptive 
functioning decreased significantly between 24 and 36 months 
(t(7)=5.07, p=0.004; Figure 3H). There was a quadratic 
association between this pattern of scores and clinical outcome 
(linear=0.19, quadratic=0.14, Figure 3G), with a linear increase 
in individual loadings from HR-Typical to HR-ASD (Figure S1), 
but higher loadings in LR than HR-Typical siblings. Furthermore, 
there was a significant effect of sex covariate on clinical 
outcome, with more males than females among HR-Atypical and HR-
ASD groups (=-0.40, p=0.002). 
Discussion 
This study uncovers independent neurodevelopmental processes 
related to clinical outcome at 36 months. We presented a data 
integration approach to longitudinal developmental data and 
early brain measures to extract intrinsic patterns of 
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variation linked across domains. Contrary to retrospective 
group comparisons, such approach exploited the power of the 
prospective design by not having a priori assumptions on 
clinical categories. Then, we examined their relation to 
clinical outcome at 36 months.  
By integrating clinical data and ERP responses to social 
stimuli at 8 months, we found a single neurodevelopmental 
process associated with clinical outcome at 36 months. At an 
individual level, this process explained more developmental 
variation in LR than HR-Atypical and HR-ASD groups, suggesting 
an association with typical development. The clinical pattern 
consisted in high levels of competence and low levels of 
symptoms. The neurophysiological correlates consist of a 
diffuse pattern of responses to gaze shifts, involving reduced 
and slower P1, increased P400 and faster N290 latency, but 
also reduced P1 to visual noise and slower P400 to direct 
gaze. This pattern suggests reduced attention capture but 
faster perceptual processing and deeper engagement to gaze 
shifts, and reduced attention capture by visual noise. Our 
previous work has already shown differences in P400 amplitude 
to dynamic gaze at 8 months between high-risk siblings with or 
without ASD outcome, and low-risk controls18. Here, we extended 
group comparison on single ERP measures to the identification 
of patterns from unlabelled data across integrated ERP 
measures linked to behavioural measures at the same age. We 
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found that higher neural engagement to a hard task like 
dynamic gaze shifts associates with high levels of visuomotor, 
but also communicative and social functioning at 8 months. 
This association might be explained by the complexity of gaze 
shift stimuli, which are likely more challenging for infants 
to process due to their dynamic nature involving rapid 
changes18. Furthermore, early sensitivity to dynamic gaze is 
fundamental to develop joint attention25, which is thought to 
be crucial for cognitive, language and social development42. 
Greater attention to social stimuli might provide, in fact, 
increased opportunities for implicit social learning and the 
development of skills (e.g. learning words, interpreting 
facial expressions, predicting actions) underpinning typical 
development. However, the high overlap between groups in 
individual variation indicates that not all HR-ASD or atypical 
siblings were deviant on this pattern, which might rather 
define a subgroup. Interestingly, the process was mostly 
driven by ERP data (Figure 2.C), suggesting that ERP measures 
are more informative about clinical outcome than behavioural 
measures in infancy. This is likely because the ERPs can 
measure the early sensory and attentional alterations that are 
more commonly described as part of emerging ASD, while 
behavioural measures are probably too noisy and not specific 
to ASD in its prodromal phase6,7. 
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By integrating longitudinal data from standardized clinical 
instruments, we aimed to capture pervasiveness of ASD symptoms 
in multiple functional domains. We found two processes 
significantly associated with clinical outcome. The first 
process indicated an increase in competence between 8 and 36 
months accompanied by low levels of ASD symptoms. It occurs in 
a step-wise, sequential manner in which motor skills develop 
first, communication skills build on that and follow in 
development, followed in turn by social skills. This process 
was present more strongly in typical development, with 
decreasing scores going from LR controls to HR-ASD siblings. 
This is consistent with previous reports of developmental 
delay, poorer adaptive functioning and higher levels of ASD 
symptoms in HR non-ASD siblings43. Furthermore, the HR-Atypical 
group was more instrument-defined than clinically based and 
included individuals with high variability in competence 
and/or ASD symptoms. Among them, some individuals might 
develop ASD later than 36 months of age, while others might 
show features of the Broad Autism Phenotype43. Previous studies 
have already shown increasing trajectories of cognitive and 
adaptive functioning in LR and HR-Typical siblings8,10. However, 
our approach to reveal this profile was novel. We only 
considered individual-level variation across measures over 
time and picked up this specific profile as explaining most of 
variance in data without any knowledge of clinical outcome. 
Thus, our results extend previous findings by showing that 
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this profile might actually represent an intrinsic 
developmental process underlying typical development. 
Previously observed differences between ASD and non-ASD 
siblings on single measures at different time-points might 
actually reflect a deviation from this underlying process. 
Furthermore, this process was highly correlated to the one 
obtained from the multimodal analysis at 8 months (see 
Supplemental Material). Thus, the neural pattern identified 
from ERP data at 8 months is likely to be associated to an 
increase in cognitive and adaptive functioning across 
development, indicating a pattern of increased developmental 
and neural functioning underpinning typical development. 
The second pattern indicated a novel profile characterized by 
an increase in ASD symptoms over time and an early increase 
followed by a plateau in visual receptive and motor function 
between 24 and 36 months. This process was present more 
strongly in HR-ASD siblings and suggests a slower rate of 
gaining skills, or even stagnation over development. A more 
far reaching interpretation is that of regression, defined as 
the loss of acquired skills later in development, usually 
between 18 and 24 months, and the later emergence of 
impairments typical of ASD44-46. Recent studies have suggested 
that social-communication impairments were already present in 
infants before regression47,48. Consistently, our pattern of 
late emerging ASD symptoms was linked to developmental 
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impairments already at 8 months, as shown by low Mullen scores 
in particular for receptive language. Furthermore, our 
findings support the recent hypothesis that regression might 
be a common process rather than an exception in ASD 
development 45,46. However, standardized scores make it 
difficult to distinguish regression from stagnation. It would 
be interesting to test whether this process could 
differentiate siblings who satisfied criteria for ASD already 
at 24 months from those who did only at 36 months. Of note, 
lower individual loadings in the HR-Typical than other 
clinical groups suggest that a reduced expression of the 
stagnation process, which entails strong cognitive skills in 
the first year of life, but slow visuomotor development and 
absence of overt ASD symptoms, promotes typical development. 
While previous neurophysiological studies investigated the 
superposition between liability to ASD and factors preventing 
ASD development49, we identified a behavioural mechanism 
associated with reduced likelihood of developing ASD in 
infants with higher liability to ASD. Future research should 
integrate genetic and neurophysiological data, to improve our 
understanding of possible genetic or environmental factors 
associated with reduced likelihood of developing ASD in 
families with higher liability.  
Taken together, our results highlight underlying developmental 
processes acting together in the first three years of life and 
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leading to different clinical outcome depending on their 
presence in the individual infant. We formally investigated 
intrinsic processes across developmental and brain data, in 
agreement with the general consensus on the necessity for data 
integration to improve our understanding of the underlying 
mechanisms for ASD. Our study adds to the literature by 
showing patterns of developmental variation linked across 
domains and across age that can help understand the unfolding 
of symptoms from the variety of early signs of ASD. The 
unsupervised approach is the strength of this study, which 
allowed us to pull apart different underlying processes 
expressing intrinsic variation in development independently 
from clinical categories. Although there is a priori evidence 
that the measures included would likely be associated with ASD 
outcome8,10,18, our statistical approach had no a priori 
assumption the relationship between measures and clinical 
categories. This approach opens up various possibilities for 
the investigation of the biological processes acting early in 
development and preceding an ASD diagnosis. Future work could 
investigate the relation of the identified neurodevelopmental 
processes to different early risk factors through the 
integration of data from different modalities (e.g. MRI, fNIRS 
or eye-tracking). Similarly, incorporating genetic data could 
aid understanding of whether a specific process is linked more 
to common variation or to single gene mutations. This would 
provide insight into trajectories of gene expression and 
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mechanisms going from genetic risk, to neurobiological 
alterations and the cognitive and behavioural differences 
observed within ASD. 
This study also has limitations. First, our longitudinal 
analysis included measures at 24 and 36 months used to inform 
clinical outcome evaluation at 36 months. However, the 
identification of underlying processes did not depend on 
clinical outcome as it was only used for post-hoc association. 
Nevertheless, process selection might have been biased, as 
shown by the fact that the identified longitudinal processes 
mainly explained variance at 24 and 36 months. Second, the 
majority in the investigated sample had a typical outcome, 
thus the processes identified might not capture the full 
variation in atypical development due to its under-
representation in the sample. Third, we could not investigate 
the expression of neurodevelopmental processes over time as 
ERPs were only available at 8 months. For the same reason, we 
could not investigate the neurophysiological correlates of the 
stagnation process, which might inform on possible protective 
factors and should be the focus of future research. Fourth, 
ERP data were based on peak detection, which might be more 
prone to noise in infants 50,51. Finally, although results show 
a clear significant trend relating to clinical outcome, there 
was substantial overlap between clinical groups. However, 
clinical categorization was not the ultimate goal of this 
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study, rather the investigation of underlying developmental 
pathways acting together in the individual infant, trans-
diagnostically, and leading to a more typical or atypical 
outcome depending on their level of expression.  
The processes identified inform on the underlying 
neurodevelopmental mechanisms associated with emerging ASD. 
Although our findings do not show underlying processes 
specific to ASD per se, they can help shaping our view on 
early ASD by showing that there is no sharp boundary between 
ASD and atypical development as the ASD phenotype goes beyond 
the limits of clinical categories set by the DSM-5.  
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Tables 
 
Table 1. Demographics 
 Overall HR-ASD HR-Atypical HR-Typical LR 
Longitudinal analysis      
 n n n n n 
 232 32 43 86 71 
Sex*      
Male 118 24 23 38 33 
Female 114 8 20 48 38 
Age mean (SD) mean (SD) mean (SD) mean (SD) mean (SD) 
8 m 8.13 (1.22) 8.03 (1.12) 8.33 (1.06) 8.24 (1.21) 7.92 (1.35) 
14 m 14.48 (1.27) 14.50 (1.32) 14.56 (1.20) 14.58 (1.29) 14.31 (1.26) 
24 m 25.39 (3.06) 24.84 (1.63) 26.40 (4.25) 25.72 (2.31) 24.63 (3.30) 
36 m 38.39 (2.32) 38.06 (1.90) 38.19 (2.05) 38.62 (2.29) 38.39 (2.69) 
Multimodal analysis      
 n n n n n 
 201 30 36 74 61 
Sex**      
Male 99 23 18 30 28 
Female 102 7 18 44 33 
30 
 
Age mean (SD) mean (SD) mean (SD) mean (SD) mean (SD) 
8 m 8.14 (1.22) 8.03 (1.05) 8.31 (1.09) 8.27 (1.16) 7.92 (1.41) 
†Note: This table shows sex (count, n) and age by clinical outcome group. Data are reported 
separately for the sample included in the longitudinal analysis and the multimodal analysis. 
‡Abbreviations: ASD= autism spectrum disorder; HR = high-risk siblings; LR = low-risk 
controls. 
* Significant difference of sex per clinical outcome: 2(3) = 9.66, p = 0.022. 
** Significant difference of sex per clinical outcome: 2(3) = 11.55, p = 0.009. 
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Figure captions 
 
Figure 1: Analysis flowchart. This figure illustrates the 
different steps of analysis for the extraction of underlying 
processes associated with clinical outcome at 36 months. Panel 
A illustrates the multimodal analysis, integrating clinical 
and ERP data both collected at 8 months, while panel B 
illustrates the longitudinal analysis, integrating behavioural 
data from standardized clinical instruments collected between 
8 and 36 months.  
Figure 2. Independent component linked across modalities. This 
figure illustrates the independent component linked across ERP 
and clinical data, both collected at 8 months, significantly 
associated to clinical outcome at 36 months (IC7). Panels A 
and B respectively show the associated sources of variation, 
namely score maps indicating the relative value of scores 
compared to the estimated noise, for ERP and clinical scores. 
Panel C presents the contribution of each measure to the 
component and D shows individual participant loadings to the 
component grouped by clinical outcome at 36 months. 
Abbreviations: SA = averted gaze shift; SD = direct gaze 
shift; FA = static averted gaze; FD = static direct gaze; Fc = 
face with static gaze (average between direct and averted); Ns 
= visual noise; A = amplitude; L = latency; GM = gross motor 
scores (MSEL); VR = visual reception scores (MSEL); FM = fine 
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motor scores (MSEL); RL = receptive language scores (MSEL); EL 
= expressive language scores (MSEL); Cm = communication scores 
(VABS); DL = daily living scores (VABS); Sc = social scores 
(VABS); Mt = motor scores (VABS); Ao = AOSI total score; MSEL 
= Mullen Scales of Early Learning; VABS = Vineland Adaptive 
Behavior Scale; AOSI = Autism Observation Scales for Infants. 
Figure 3. Independent components linked across development. 
This figure shows results for the independent components 
obtained from the analysis of longitudinal clinical data: IC1 
(top row) and IC3 (bottom row). Panels A and E show the 
associated sources of variation, namely score maps indicating 
the relative value of scores compared to the estimated noise, 
for clinical scores at different time-points respectively for 
the two independent processes identified. Similarly, panels B 
and F present the contribution of each time-point to the 
components, while panels C and G show individual participant 
loadings to the components grouped by clinical outcome at 36 
months. Finally, panels D and H show the trajectories of 
average competence across all functional domains (VR, FM, RL, 
EL, Cm, DL, Sc, Mt) respectively for the two independent 
processes identified. The red line marks the median of scores 
as shown in panels A and E, and indicates: (D) a significant 
increase in average competence between 8 and 14 months (*, 
p<.05), reaching its peak at 24 months (***, p<.001); (H) a 
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significant decrease in average competence between 24 and 36 
months (**, p<0.005).  
Abbreviations: VR = visual reception scores (MSEL); FM = fine 
motor scores (MSEL); RL = receptive language scores (MSEL); EL 
= expressive language scores (MSEL); Cm = communication scores 
(VABS); DL = daily living scores (VABS); Sc = social scores 
(VABS); Mt = motor scores (VABS); Ao = ASD symptoms as measured 
by the AOSI total score at 8 and 14 months, and ADOS total score 
at 24 and 36 months; MSEL = Mullen Scales of Early Learning; 
VABS = Vineland Adaptive Behavior Scale; AOSI = Autism 
Observation Scales for Infants; ADOS = Autism Diagnostic 
Observation Schedule 
 
 
 
 
